Esin Kotiloğlu Karaa

433 total citations
9 papers, 285 citations indexed

About

Esin Kotiloğlu Karaa is a scholar working on Ophthalmology, Oncology and Surgery. According to data from OpenAlex, Esin Kotiloğlu Karaa has authored 9 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Ophthalmology, 4 papers in Oncology and 3 papers in Surgery. Recurrent topics in Esin Kotiloğlu Karaa's work include Ocular Oncology and Treatments (7 papers), Cancer-related Molecular Pathways (4 papers) and interferon and immune responses (1 paper). Esin Kotiloğlu Karaa is often cited by papers focused on Ocular Oncology and Treatments (7 papers), Cancer-related Molecular Pathways (4 papers) and interferon and immune responses (1 paper). Esin Kotiloğlu Karaa collaborates with scholars based in United Kingdom, Türkiye and Israel. Esin Kotiloğlu Karaa's co-authors include Irene Scheimberg, Mandeep S. Sagoo, M. Ashwin Reddy, Zerrin Onadim, Catriona Duncan, Tanzina Chowdhury, Ido Didi Fabian, Shin‐ichi Ohnuma, Ender Pehlıvanoğlu and Deniz Ertem and has published in prestigious journals such as PEDIATRICS, Oncogene and Ophthalmology.

In The Last Decade

Esin Kotiloğlu Karaa

9 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Esin Kotiloğlu Karaa United Kingdom 7 177 90 85 56 51 9 285
CarolL Shields United States 7 240 1.4× 69 0.8× 90 1.1× 78 1.4× 22 0.4× 16 338
Raksha Rao India 9 228 1.3× 77 0.9× 84 1.0× 25 0.4× 37 0.7× 22 336
Sonia Callejo Canada 9 199 1.1× 97 1.1× 84 1.0× 21 0.4× 27 0.5× 22 303
Berçin Tarlan Türkiye 9 267 1.5× 110 1.2× 119 1.4× 38 0.7× 20 0.4× 29 383
Jarin Saktanasate United States 11 309 1.7× 99 1.1× 109 1.3× 33 0.6× 24 0.5× 12 402
Kenneth J. Taubenslag United States 9 105 0.6× 210 2.3× 76 0.9× 29 0.5× 97 1.9× 21 416
Kiran Turaka United States 10 328 1.9× 101 1.1× 104 1.2× 25 0.4× 21 0.4× 20 405
Renelle Pointdujour‐Lim United States 12 236 1.3× 87 1.0× 120 1.4× 27 0.5× 10 0.2× 37 342
Eva Biewald Germany 12 311 1.8× 78 0.9× 110 1.3× 33 0.6× 23 0.5× 45 385
Yingwen Bi China 9 81 0.5× 30 0.3× 69 0.8× 58 1.0× 18 0.4× 29 226

Countries citing papers authored by Esin Kotiloğlu Karaa

Since Specialization
Citations

This map shows the geographic impact of Esin Kotiloğlu Karaa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esin Kotiloğlu Karaa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esin Kotiloğlu Karaa more than expected).

Fields of papers citing papers by Esin Kotiloğlu Karaa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esin Kotiloğlu Karaa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esin Kotiloğlu Karaa. The network helps show where Esin Kotiloğlu Karaa may publish in the future.

Co-authorship network of co-authors of Esin Kotiloğlu Karaa

This figure shows the co-authorship network connecting the top 25 collaborators of Esin Kotiloğlu Karaa. A scholar is included among the top collaborators of Esin Kotiloğlu Karaa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esin Kotiloğlu Karaa. Esin Kotiloğlu Karaa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Karaa, Esin Kotiloğlu, Tanzina Chowdhury, Irene Scheimberg, et al.. (2022). Systemic adjuvant chemotherapy for advanced malignant ocular medulloepithelioma. Eye. 37(5). 947–952. 3 indexed citations
2.
Davies, Helen, Kevin D. Broad, Zerrin Onadim, et al.. (2021). Whole-Genome Sequencing of Retinoblastoma Reveals the Diversity of Rearrangements Disrupting RB1 and Uncovers a Treatment-Related Mutational Signature. Cancers. 13(4). 754–754. 18 indexed citations
3.
Price, Elizabeth, Roopal Patel, Irene Scheimberg, et al.. (2021). MYCN amplification levels in primary retinoblastoma tumors analyzed by Multiple Ligation-dependent Probe Amplification. Ophthalmic Genetics. 42(5). 604–611. 7 indexed citations
4.
Fabian, Ido Didi, Zerrin Onadim, Esin Kotiloğlu Karaa, et al.. (2018). The management of retinoblastoma. Oncogene. 37(12). 1551–1560. 180 indexed citations
5.
Price, Elizabeth, Roopal Patel, Esin Kotiloğlu Karaa, et al.. (2018). Detection and reporting of RB1 promoter hypermethylation in diagnostic screening. Ophthalmic Genetics. 39(4). 526–531. 13 indexed citations
6.
Thaung, Caroline & Esin Kotiloğlu Karaa. (2018). Standard reporting of high-risk histopathology features in retinoblastoma.. PubMed. 31(101). 17–17. 2 indexed citations
7.
Fabian, Ido Didi, Andrew W. Stacey, Tanzina Chowdhury, et al.. (2017). High-Risk Histopathology Features in Primary and Secondary Enucleated International Intraocular Retinoblastoma Classification Group D Eyes. Ophthalmology. 124(6). 851–858. 24 indexed citations
8.
Tutar, Engin, Deniz Ertem, Esin Kotiloğlu Karaa, & Ender Pehlıvanoğlu. (2008). Endoscopic and Histopathologic Findings Associated with H. pylori Infection in Very Young Children. Digestive Diseases and Sciences. 54(1). 111–117. 8 indexed citations
9.
Ertem, Deniz, et al.. (2002). A Rare and Often Unrecognized Cause of Hematochezia and Tenesmus in Childhood: Solitary Rectal Ulcer Syndrome. PEDIATRICS. 110(6). e79–e79. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by CarolL Shields Breakdown of academic impact, for papers by Raksha Rao Breakdown of academic impact, for papers by Sonia Callejo Breakdown of academic impact, for papers by Berçin Tarlan Breakdown of academic impact, for papers by Jarin Saktanasate Breakdown of academic impact, for papers by Kenneth J. Taubenslag Breakdown of academic impact, for papers by Kiran Turaka Breakdown of academic impact, for papers by Renelle Pointdujour‐Lim Breakdown of academic impact, for papers by Eva Biewald Breakdown of academic impact, for papers by Yingwen Bi
Rankless by CCL
2026